Register February 9th and Save Up To $200 Download Brochure | Register Today | Submit Poster (no form required) Just Some of the Attendees Include: Abbott Labs - Research Chemist Achaogen - Scientist - Assoc Dir Bus Dev - Sr VP Chemistry Achillion Pharmaceuticals Inc - Dir Antimicrobial Drug Discovery Albany Molecular Research Inc - Sr Research Sci I American Univ - Asst Prof AMSSINC - President AstraZeneca Pharmaceuticals Inc - Principal Scientist AVI Biopharma - VP Bus Dev - Sr VP R&D Battelle Memorial -Research Scientist Basilea Pharmaceutica AG - CSO Biolog Inc - Sr Scientist Biological Defense Research - Dir Deputy Head Burnham Institute - Staff Scientist - Assoc Prof Colorado State Univ - Microbiology - Prof & Assoc Head Graduate Studies & Research Ctrs for Disease Control & Prevention - Assoc Dir Lab Science CUBRC - Dir Microbiology Defense Research Establishment Suffield - Defence Scientist ENANTA Pharmaceuticals - Sr VP R&D - Project Mgr GlaxoSmithKline - VP Biology & Infectious Diseases John Innes Ctr - Head KaloBios Pharmaceuticals Inc - VP Research Micromyx - CEO MIGENIX Inc - CSO - VP Clinical & Regulatory Mpex Pharmaceuticals - VP Drug Dev NIH NIAID - Program Officer NOVEXEL - VP Bus Dev - Sr Research Scientist Novozymes AS - Sr Mgr Pacific Northwest Natl Lab - Scientist III Pfizer Global R&D - Assoc Dir Midwest Nonclinical Studies - Exec Dir Antibacterials Discovery PriCara - Therapeutic Area Lead Anti Infectives Rib X Pharmaceuticals Inc - Chief Research Officer Rohm & Haas Co - Tech Mgr Southern Methodist Univ - Prof Theravance - VP TNO Nutrition & Food Research - Research Mgr - Sr Scientist Univ Of California San Diego - Prof Pediatrics & Pharmacy University of Chicago - Chemistry Univ of Pittsburgh - Assoc Prof Univ of Saskatchewan - Dean Uppsala Univ - Prof VA Medical Ctr Cleveland - Section Chief Wyeth Research Labs - Dir Chemical & Screening Sciences Keynote Address: The Challenges of Emerging Antimicrobial Resistance Fred C. Tenover, Ph.D. (D) A.B.M.M., Associate Director for Laboratory Science, Division of Healthcare Quality Promotion, Centers for Disease Control And Prevention Sessions: Genomics-Lessons Learned Bioinformatics for Predicting Novel Targets Optimizing b-Lactamase Inhibition >From Discovery to Delivery-Novel Insights Resistance is Futile Novel Targets Emerging Technologies and Drug Designs Call For Posters: Showcase your research and save an additional $50 by submitting a poster. Click here and secure your poster board today. As an added benefit one poster presenter will be given the opportunity to present a brief oral presentation of their work. The presentations will be selected from all abstracts submitted prior to the deadline on February 26, 2007. Corporate Support: Lead Sponsoring Publications: Sponsoring Publications: Sponsorship Opportunities Available: This conference is specifically targeted for a high-level audience in pharma, biotech industry, and academia and provides many opportunities for collaborations in addition to our variety of available sponsor packages. For complete details on sponsorship opportunities contact: David Karp at dkarp at healthtech.com, phone: 781-972-5483 For Complete Conference Details Visit: www.healthtech.com/2007/bac/index.asp Distinguished Faculty David L. Pompliano, Ph.D., Vice President, Biology, Infectious Diseases, Center for Excellence in Drug Discovery, GlaxoSmithKline Scott D. Mills, Ph.D., Principal Scientist, Infection Discovery, AstraZeneca R&D Jason McDermott, M.D., Ph.D., Scientist III, Computational Sciences & Mathematics Division, Pacific Northwest National Lab (Battelle) Lawrence Wiater, Ph.D., Senior Scientist, Research and Development, Biolog, Inc. Michael N. Dudley, Pharm.D., FIDSA, Vice President, Drug Development, Mpex Pharmaceuticals Robert Bonomo, M.D., Section Chief, Department of Infectious Diseases, Louis Stokes VAMC Aranapakam M. Venkatesan, Ph.D., Chemical and Screening Sciences, Wyeth Research Christine Miossec, Ph.D., Senior Research Scientist, Novexel Nafsika Fred C. Tenover, Ph.D. (D) A.B.M.M., Associate Director for Laboratory Science, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention Georgopapadakou, Ph.D., Vice President Infectious Diseases, MethylGene Inc., Canada Lynn L. Silver, Ph.D., LL Silver Consulting, LLC Victor Nizet, M.D., Ph.D., Associate Professor/Chief, Division of Pharmacology & Drug Discovery, University of California, San Diego Michael J. Pucci, Ph.D., Senior Director, Discovery, Achillion Pharmaceuticals Hans-Henrik Kristensen, Ph.D., Senior Manager, Anti-infective Discovery, Novozymes A/S Herbert Schweizer Ph.D., Professor, Department of Microbiology, Immunology and Pathology, Colorado State University Mira Hinman, Ph.D., Associate Research Investigator, Target and Lead Discovery, Global Pharmaceutical R&D, Abbott Laboratories Christopher Bebbington, Ph.D., Vice President, Research, KaloBios Pharmaceuticals Inc. Graham Johnson, Ph.D., Chief Research Officer, Discovery, Rib-X Pharmaceuticals Inc. John Cherwonogrodzky, Ph.D., Defence Scientist, Department of National Defence, Canada If the above information is not of interest to you, please disregard and we apologize for any inconvenience this may have caused. To be omitted from further emails, click here or visit www.chiresource.com/rmv.asp Cambridge Healthtech Institute | 250 First Avenue, Suite 300 | Needham, MA 02494 | Phone: 781.972.5400 or toll free 888.999.6288 | Fax: 781.972.5425 | Web: www.healthtech.com